NoRinse eyes $2 mln revenue from India by March 2017

US-based waterless bathing brand NoRinse, which entered India earlier this year, is eyeing a turnover of USD 2 million by March 2017.
"India is a pretty big market. We have an order pipeline of USD 2 million, which is expected to close by March 2017. We are targeting USD 20 million in next 5 years. India should contribute more than 20 per cent of global sales in next 5 years," NoRinse US-India Founder and CEO Puneet Gupta told PTI.
The company, which counts NASA, US Military, Lockheed Martin as its clients, is focusing on the healthcare segment, defence industry, homecare (post surgery) and the over the counter (OTC) space in India.

NoRinse partners with experts in each segment to market and distribute its products and the company is in talks with a leading pharma company to distribute its products in the OTC space.
The company has tied-up with Hinduja Hospital, Wockhardt Hospitals, Gangaram Hospital among others in India.
With a product portfolio includes waterless shampoo, waterless body wash, shampoo cap and body wipes, NoRinse is focusing on the tier I cities initially but plans to have a pan-India presence by 2018.

Currently the company manufactures all its products in the US and exports it to over 15 countries including India, but it plans to set-up a manufacturing unit in the country in the next three years.

"In the first phase we are bringing all the goods from US because we have a manufacturing set-up in US. In second phase we will repack in India and in third phase we will manufacture in India. Within three years we have plans to have our own manufacturing plant in India," he said.
NoRinse also has products for the pet care industry but Gupta said they would wait for at least a year before launching it in India.